{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:20:13Z","timestamp":1790112013436,"version":"4.0.1"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230449-4\"><jats:title>Importance<\/jats:title><jats:p>Although a patient\u2019s age may be the only objective figure that can be used as a reference indicator in selecting the type of prosthesis in heart valve surgery, different clinical guidelines use different age criteria.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230449-5\"><jats:title>Objective<\/jats:title><jats:p>To explore the age-associated survival-hazard functions associated with prosthesis type in aortic valve replacement (AVR) and mitral valve replacement (MVR).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230449-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study compared the long-term outcomes associated with mechanical and biologic prostheses in AVR and MVR according to recipient\u2019s age using a nationwide administrative data from the Korean National Health Insurance Service. To reduce the potential treatment-selection bias between mechanical and biologic prostheses, the inverse-probability-of-treatment-weighting method was used. Participants included patients who underwent AVR or MVR in Korea between 2003 and 2018. Statistical analysis was performed between March 2022 and March 2023.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230449-7\"><jats:title>Exposures<\/jats:title><jats:p>AVR, MVR, or both AVR and MVR with mechanical or biologic prosthesis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230449-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary end point was all-cause mortality after receiving prosthetic valves. The secondary end points were the valve-related events, including the incidence of reoperation, systemic thromboembolism, and major bleeding.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230449-9\"><jats:title>Results<\/jats:title><jats:p>Of the total of 24\u202f347 patients (mean [SD] age, 62.5 [7.3] years; 11\u202f947 [49.1%] men) included in this study, 11\u202f993 received AVR, 8911 received MVR, and 3470 received both AVR and MVR simultaneously. Following AVR, bioprosthesis was associated with significantly greater risks of mortality than mechanical prosthesis in patients younger than 55 years (adjusted hazard ratio [aHR], 2.18; 95% CI, 1.32-3.63; <jats:italic>P<\/jats:italic>\u2009=\u2009.002) and in those aged 55 to 64 years (aHR, 1.29; 95% CI, 1.02-1.63; <jats:italic>P<\/jats:italic>\u2009=\u2009.04), but the risk of mortality reversed in patients aged 65 years or older (aHR, 0.77; 95% CI, 0.66-0.90; <jats:italic>P<\/jats:italic>\u2009=\u2009.001). For MVR, the risk of mortality was also greater with bioprosthesis in patients aged 55 to 69 years (aHR, 1.22; 95% CI, 1.04-1.44; <jats:italic>P<\/jats:italic>\u2009=\u2009.02), but there was no difference for patients aged 70 years or older (aHR, 1.06; 95% CI, 0.79-1.42; <jats:italic>P<\/jats:italic>\u2009=\u2009.69). The risk of reoperation was consistently higher with bioprosthesis, regardless of valve position, in all age strata (eg, MVR among patients aged 55-69 years: aHR, 7.75; 95% CI, 5.14-11.69; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001); however, the risks of thromboembolism and bleeding were higher in patients aged 65 years and older after mechanical AVR (thromboembolism: aHR, 0.55; 95% CI, 0.41-0.73; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001; bleeding: aHR, 0.39; 95% CI, 0.25-0.60; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), with no differences after MVR in any age strata.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230449-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this nationwide cohort study, the long-term survival benefit associated with mechanical prosthesis vs bioprosthesis persisted until age 65 years in AVR and age 70 years in MVR.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.14671","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T15:33:34Z","timestamp":1684769614000},"page":"e2314671","source":"Crossref","is-referenced-by-count":18,"title":["Evaluating Reference Ages for Selecting Prosthesis Types for Heart Valve Replacement in Korea"],"prefix":"10.1001","volume":"6","author":[{"given":"Sung Jun","family":"Park","sequence":"first","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Jung","family":"Ok","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Jee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonok","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Min","family":"Ahn","sequence":"additional","affiliation":[{"name":"Divison of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Hee","family":"Kim","sequence":"additional","affiliation":[{"name":"Divison of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Sung","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Bum","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"issue":"5","key":"zoi230449r1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/01.CIR.66.5.1105","article-title":"The effect of aortic valve replacement on survival.","volume":"66","author":"Schwarz","year":"1982","journal-title":"Circulation"},{"issue":"14","key":"zoi230449r2","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1001\/jama.2015.3164","article-title":"Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years.","volume":"313","author":"Chikwe","year":"2015","journal-title":"JAMA"},{"issue":"19","key":"zoi230449r3","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1056\/NEJMoa1613792","article-title":"Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement.","volume":"377","author":"Goldstone","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi230449r4","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jacc.2007.10.058","article-title":"Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications.","volume":"51","author":"Russo","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"zoi230449r5","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"zoi230449r6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease.","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"4","key":"zoi230449r7","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S0735-1097(00)00834-2","article-title":"Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial.","volume":"36","author":"Hammermeister","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"zoi230449r8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/heart.89.7.715","article-title":"Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses.","volume":"89","author":"Oxenham","year":"2003","journal-title":"Heart"},{"issue":"20","key":"zoi230449r9","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.jacc.2009.07.032","article-title":"Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.","volume":"54","author":"Stassano","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"zoi230449r10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jtcvs.2012.01.024","article-title":"Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.","volume":"144","author":"Weber","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"zoi230449r11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/ije\/dyw253","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea.","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"9","key":"zoi230449r12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","article-title":"Cardiovascular research using the Korean National Health Information Database.","volume":"50","author":"Choi","year":"2020","journal-title":"Korean Circ J"},{"issue":"5","key":"zoi230449r13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4093\/dmj.2014.38.5.395","article-title":"Background and data configuration process of a nationwide population-based study using the korean national health insurance system.","volume":"38","author":"Song","year":"2014","journal-title":"Diabetes Metab J"},{"issue":"6","key":"zoi230449r14","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.athoracsur.2021.07.035","article-title":"Real-world outcomes of on- vs off-pump coronary bypass surgery: result from Korean Nationwide Cohort.","volume":"113","author":"Park","year":"2022","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"zoi230449r15","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/sim.v38.5","article-title":"Propensity-score matching with competing risks in survival analysis.","volume":"38","author":"Austin","year":"2019","journal-title":"Stat Med"},{"issue":"13","key":"zoi230449r16","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/jama.2014.12679","article-title":"Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years.","volume":"312","author":"Chiang","year":"2014","journal-title":"JAMA"},{"issue":"9","key":"zoi230449r17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019929","article-title":"Predictors of use and outcomes of mechanical valve replacement in the United States (2008-2017).","volume":"10","author":"Alkhouli","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"34","key":"zoi230449r18","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1093\/eurheartj\/ehv580","article-title":"Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years.","volume":"37","author":"Glaser","year":"2016","journal-title":"Eur Heart J"},{"issue":"15","key":"zoi230449r19","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/eurheartj\/ehx562","article-title":"Inter-ethnic differences in valve morphology, valvular dysfunction, and aortopathy between Asian and European patients with bicuspid aortic valve.","volume":"39","author":"Kong","year":"2018","journal-title":"Eur Heart J"},{"issue":"2","key":"zoi230449r20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcin.2019.08.056","article-title":"Racial and ethnic differences in treatment and outcomes of severe aortic stenosis: a review.","volume":"13","author":"Wilson","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"zoi230449r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.46026","article-title":"Analysis of anticoagulation therapy and anticoagulation-related outcomes among asian patients after mechanical valve replacement.","volume":"5","author":"Huang","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi230449r22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1182\/blood-2015-02-627042","article-title":"Race influences warfarin dose changes associated with genetic factors.","volume":"126","author":"Limdi","year":"2015","journal-title":"Blood"},{"issue":"4","key":"zoi230449r23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation.","volume":"50","author":"Shen","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2805052\/park_2023_oi_230449_1683743110.49899.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T15:33:38Z","timestamp":1684769618000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2805052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.14671","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]}}}